Integrative Physiology/Experimental Medicine |
Overexpression and Experimental Murine AtherosclerosisFrom the Department of Cardiology (J.B.-S., S.M.-A., A.B., G.K.), Tel Aviv Sourasky Medical Center, Israel; the Department of Pathology (A.A.), Sheba Medical Center, Tel-Hashomer, Israel; the Sackler School of Medicine (J.B.-S., A.A., S.M.-A., A.B., G.K., J.G.), Tel Aviv University, Israel; and the Lipid Metabolic Unit (A.R.), Tel Aviv Sourasky Medical Center, Israel.
Correspondence to Jacob George, MD, Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. E-mail jacobg{at}post.tau.ac.il
Background— Lymphocytes play an important role in the progression of atherosclerosis. Recently, hypoxia inducible factor-1 (HIF-1) was found to attenuate inflammation by regulating T cell activation and cytokine production. We studied the effects of overexpression of HIF-1
in ApoE knockout murine lymphocytes, on experimental atherosclerosis.
Methods and Results— ApoE–/– mice were submitted to intravenous hydrodynamic injection of empty plasmid or HIF-1
P564A (HIF-1
mutated stabilized construct). Robust expression of HIF-1
was evident in spleen cells of recipient animals. Increased expression of IL-10 as well as decreased expression of IFN-
was measured in splenocytes of HIF-1
–treated mice by RT-PCR. One week postinjection, antibody array analysis revealed a pattern consistent with a T helper 1 to T helper 2 shift. On sacrifice, assessment of aortic sinus lesions revealed a significant reduction in plaque size in HIF-1
injected mice. A reduced expression of IFN-
was evident in CD4+ spleen-derived lymphocytes and aortas of HIF-1
–injected mice.
Conclusions— HIF-1
expression in mouse lymphocytes is associated with a reduced IFN-
expression and attenuation of experimental atherosclerosis.
We used a HIF-1
plasmid delivered by hydrodynamic injection to assess the effects on cellular immunity and atherosclerotic plaque size in ApoE–/– mice. HIF-1
plasmid was expressed predominantly in CD4 cells and shifted their phenotype to the TH2 lineage concomitantly with a significant reduction in atherosclerotic plaque size.
Key Words: atherosclerosis cytokines immune system hypoxia-inducible factor-1 T lymphocytes
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |